Skip to content
Open access · CC-BY via OpenAlex

Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice

Daisuke Ito, Hiroyasu Ito, Tatsuya Ando, Yasuhiro Sakai, Takayasu Ideta, Ken J. Ishii, Tetsuya Ishikawa, Masahito Shimizu

Hepatology Communications · 2023 · ▲ 3 citations

Abstract

Background: Various vaccine adjuvants have been developed to eliminate HBV from patients with chronic HBV infection. In addition, spermidine (SPD), a type of polyamine, has been reported to enhance the activity of immune cells. In the present study, we investigated whether the combination of SPD and vaccine adjuvant enhances the HBV antigen-specific immune response to HBV vaccination. Methods: Wild-type and HBV-transgenic (HBV-Tg) mice were vaccinated 2 or 3 times. SPD was orally administered in drinking water. Cyclic guanosine monophosphate-AMP (cGAMP) and nanoparticulate CpG-ODN (K3-SPG) were used as the HBV vaccine adjuvants. The HBV antigen-specific immune response was evaluated by measuring the HBsAb titer in blood collected over time and the number of interferon-γ producing cells by enzyme-linked immunospot assay. Results: The administration of HBsAg + cGAMP + SPD or HBsAg + K3-SPG + SPD significantly enhanced HBsAg-specific interferon-γ production by CD8 T cells from wild-type and HBV-Tg mice. The administration of HBsAg, cGAMP, and SPD increased serum HBsAb levels in wild-type and HBV-Tg mice. In HBV-Tg mice, the administration of SPD + cGAMP or SPD + K3-SPG with HBV vaccination significantly reduced HBsAg levels in the liver and serum. CONCLUSIONS: These results indicate that the combination of HBV vaccine adjuvant and SPD induces a stronger humoral and cellular immune response through T-cell activation. These treatments may support the development of a strategy to completely eliminate HBV.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1097/hc9.0000000000000104
Canonical
link ↗
Fetched
2026-10-31 MST

Cite this

APA
Ito, D., Ito, H., Ando, T., Sakai, Y., Ideta, T., Ishii, K.J., Ishikawa, T., &amp; Shimizu, M. (2023). Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice. <em>Hepatology Communications</em>. https://doi.org/10.1097/hc9.0000000000000104
Vancouver
Ito D, Ito H, Ando T, Sakai Y, Ideta T, Ishii KJ, et al. Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice. Hepatology Communications. 2023. doi:10.1097/hc9.0000000000000104.
BibTeX
@article{daisuke2023Spermi, title = {Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice}, author = {Daisuke Ito and Hiroyasu Ito and Tatsuya Ando and Yasuhiro Sakai and Takayasu Ideta and Ken J. Ishii and Tetsuya Ishikawa and Masahito Shimizu}, journal = {Hepatology Communications}, year = {2023}, doi = {10.1097/hc9.0000000000000104}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings